Who is sponsoring NCT02555319?

NCT02555319 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT02555319?

Interventions in NCT02555319: Transcatheter Pulmonary Valve (TPV).

What condition does NCT02555319 study?

NCT02555319 studies Congenital Heart Defects, Cardiovascular Abnormalities, Pulmonary Valve Insufficiency, Pulmonary Valve Stenosis.

Is NCT02555319 still recruiting?

NCT02555319 is currently completed. Last updated 6 February 2023.

Last reviewed 2023-02-06 · How we verify

NCT02555319

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Feasibility Study to Evaluate the Safety and Short-term Effectiveness of Transcatheter Pulmonary Valve (TPV)

Completed NA Last updated 6 February 2023

What this trial tests

NA trial testing Transcatheter Pulmonary Valve (TPV) in Congenital Heart Defects in 10 participants. Completed in 25 October 2021.

Timeline

26 August 2015

Primary endpoint
14 April 2017

25 October 2021

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	26 August 2015
Primary completion	14 April 2017
Estimated completion	25 October 2021
Sites	1 location across South Korea

Drugs / interventions tested

Transcatheter Pulmonary Valve (TPV)

Conditions studied

Congenital Heart Defects — all drugs for Congenital Heart Defects →
Cardiovascular Abnormalities — all drugs for Cardiovascular Abnormalities →
Pulmonary Valve Insufficiency — all drugs for Pulmonary Valve Insufficiency →
Pulmonary Valve Stenosis — all drugs for Pulmonary Valve Stenosis →

Sponsor

Seoul National University Hospital

Who can join

10 and older, any sex, with Congenital Heart Defects or Cardiovascular Abnormalities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the safety and short-term effectiveness of implantation of Transcatheter Pulmonary Valve (TPV) for the treatment of congenital heart disease with pulmonary valve disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Successful Feasibility Human Trial of a New Self-Expandable Percutaneous Pulmonary Valve (Pulsta Valve) Implantation Using Knitted Nitinol Wire Backbone and Trileaflet α-Gal-Free Porcine Pericardial Valve in the Native Right Ventricular Outflow Tract.
Kim GB, Song MK, Bae EJ, Park EA, et al · · 2018 · cited 47× · PMID 29871940 · DOI 10.1161/circinterventions.118.006494

Verify or expand the search:

Other recruiting trials for Congenital Heart Defects

Currently open trials in the same condition.

NCT07019857 — Impact of Thymectomy on Immunity in Infants After Cardiac Surgery · NA · recruiting
NCT06442592 — Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects · NA · recruiting
NCT06267859 — Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children · EARLY_PHASE1 · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02555319 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 6 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02555319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing